Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Schizophrenia

  Free Subscription


Articles published in Acta Psychiatr Scand

Retrieve available abstracts of 92 articles:
HTML format



Single Articles


    July 2021
  1. FUJIWARA M, Yamada Y, Shimazu T, Kodama M, et al
    Encouraging participation in colorectal cancer screening for people with schizophrenia: A randomized controlled trial.
    Acta Psychiatr Scand. 2021 Jul 9. doi: 10.1111/acps.13348.
    PubMed     Abstract available


  2. SUAREZ-PINILLA P, Suarez-Pinilla M, Setien-Suero E, Ortiz-Garcia de la Foz V, et al
    Stability of schizophrenia diagnosis in a ten-year longitudinal study on first episode of non-affective psychosis: conclusions from the PAFIP cohort.
    Acta Psychiatr Scand. 2021 Jul 6. doi: 10.1111/acps.13344.
    PubMed     Abstract available


    June 2021
  3. BHAVSAR V, Kepinska AP
    Schizophrenia, catatonic schizophrenia and poliovirus - a role for natural experiments?
    Acta Psychiatr Scand. 2021;143:469-471.
    PubMed    


    May 2021
  4. SHOHAM N, Eskinazi M, Hayes JF, Lewis G, et al
    Associations Between Psychosis and Visual Acuity Impairment: A Systematic Review and Meta-Analysis.
    Acta Psychiatr Scand. 2021 May 24. doi: 10.1111/acps.13330.
    PubMed     Abstract available


    April 2021
  5. MARWAHA S, Hett D, Johnson S, Fowler D, et al
    The impact of manic symptoms in first-episode psychosis: findings from the UK National EDEN study.
    Acta Psychiatr Scand. 2021 Apr 16. doi: 10.1111/acps.13307.
    PubMed     Abstract available


  6. SANKARANARAYANAN A, Pratt R, Anoop A, Smith A, et al
    Serum Lipids and Suicidal Risk among Patients with Schizophrenia Spectrum Disorders: Systematic Review and Meta-Analysis.
    Acta Psychiatr Scand. 2021 Apr 9. doi: 10.1111/acps.13305.
    PubMed     Abstract available


    March 2021
  7. HANIN C, Arnulf I, Maranci JB, Lecendreux M, et al
    Narcolepsy and psychosis: a systematic review.
    Acta Psychiatr Scand. 2021 Mar 29. doi: 10.1111/acps.13300.
    PubMed     Abstract available


  8. ANTTI T, Heidi T, Mary C, David C, et al
    Incidence of schizophrenia and influence of prenatal and infant exposure to viral infectious diseases.
    Acta Psychiatr Scand. 2021 Mar 13. doi: 10.1111/acps.13295.
    PubMed     Abstract available


  9. LAHTEENVUO M, Batalla A, Luykx JJ, Mittendorfer-Rutz E, et al
    Morbidity and mortality in schizophrenia with comorbid substance use disorders.
    Acta Psychiatr Scand. 2021 Mar 1. doi: 10.1111/acps.13291.
    PubMed     Abstract available


    February 2021
  10. FORNARO M
    There are no "side" effects, just "core" effects of antipsychotic pharmacotherapy.
    Acta Psychiatr Scand. 2021;143:99-100.
    PubMed    


    January 2021
  11. TAYLOR CL, Brown HK, Saunders NR, Barker LC, et al
    Accidental injury, self-injury and assault among children of women with schizophrenia: a population-based cohort study.
    Acta Psychiatr Scand. 2021 Jan 27. doi: 10.1111/acps.13281.
    PubMed     Abstract available


  12. SALAGRE E, Grande I, Jimenez E, Mezquida G, et al
    Trajectories of suicidal ideation after first-episode psychosis: a growth mixture modeling approach.
    Acta Psychiatr Scand. 2021 Jan 27. doi: 10.1111/acps.13279.
    PubMed     Abstract available


    December 2020
  13. WAKUDA T, Takei N
    'Opening doors' for long-term institutionalised patients with schizophrenia in Japan.
    Acta Psychiatr Scand. 2020 Dec 19. doi: 10.1111/acps.13269.
    PubMed     Abstract available


    November 2020
  14. HOLM M, Taipale H, Tanskanen A, Tiihonen J, et al
    Employment among people with schizophrenia or bipolar disorder: a population-based study using nationwide registers.
    Acta Psychiatr Scand. 2020 Nov 5. doi: 10.1111/acps.13254.
    PubMed     Abstract available


    July 2020
  15. PERRY BI, Upthegrove R, Crawford O, Jang S, et al
    Cardiometabolic Risk Prediction Algorithms for Young People with Psychosis: A Systematic Review and Exploratory Analysis.
    Acta Psychiatr Scand. 2020 Jul 12. doi: 10.1111/acps.13212.
    PubMed     Abstract available


  16. TAKEUCHI H, Borlido C, Sanches M, Teo C, et al
    Adherence to Clozapine vs. Other Antipsychotics in Schizophrenia.
    Acta Psychiatr Scand. 2020 Jul 6. doi: 10.1111/acps.13208.
    PubMed     Abstract available


    May 2020
  17. VILLASANTE-TEZANOS AG, Rohde C, Nielsen J, de Leon J, et al
    Pneumonia risk: approximately one-third is due to clozapine and two-thirds is due to treatment-ressistant schizophrenia.
    Acta Psychiatr Scand. 2020 May 16. doi: 10.1111/acps.13184.
    PubMed     Abstract available


    April 2020
  18. MONTAG C, Brandt L, Lehmann A, de Millas W, et al
    Cognitive and Emotional Empathy in Individuals at Clinical High Risk of Psychosis.
    Acta Psychiatr Scand. 2020 Apr 27. doi: 10.1111/acps.13178.
    PubMed     Abstract available


    March 2020
  19. SISKIND D, Nielsen J
    Clozapine: a fine balance.
    Acta Psychiatr Scand. 2020;141:175-177.
    PubMed    


  20. KAROW A, Brettschneider C, Helmut Konig H, Correll CU, et al
    Better care for less money: cost-effectiveness of integrated care in multi-episode patients with severe psychosis.
    Acta Psychiatr Scand. 2020;141:221-230.
    PubMed     Abstract available


  21. RUBIO JM, Kane JM
    How and when to use clozapine.
    Acta Psychiatr Scand. 2020;141:178-189.
    PubMed     Abstract available


    February 2020
  22. LYNGSTAD SH, Bettella F, Aminoff SR, Athanasiu L, et al
    Associations between schizophrenia polygenic risk and apathy in schizophrenia spectrum disorders and healthy controls.
    Acta Psychiatr Scand. 2020 Feb 24. doi: 10.1111/acps.13167.
    PubMed     Abstract available


  23. PRIES LK, Klingenberg B, Menne-Lothmann C, Decoster J, et al
    Polygenic liability for schizophrenia and childhood adversity influence daily-life emotion dysregulation and psychosis proneness.
    Acta Psychiatr Scand. 2020 Feb 6. doi: 10.1111/acps.13158.
    PubMed     Abstract available


    January 2020
  24. JONES R, MacCabe JH, Price MJ, Xiangxin L, et al
    Effect of age on the relative efficacy of clozapine in schizophrenia.
    Acta Psychiatr Scand. 2020 Jan 24. doi: 10.1111/acps.13156.
    PubMed     Abstract available


    December 2019
  25. JACKSON AJ, Miller BJ
    Meta-analysis of total and differential white blood cell counts in schizophrenia.
    Acta Psychiatr Scand. 2019 Dec 18. doi: 10.1111/acps.13140.
    PubMed     Abstract available


  26. MARTLAND R, Stubbs B
    High-intensity interval training: an adjunctive treatment for schizophrenia spectrum disorders?
    Acta Psychiatr Scand. 2019;140:495-497.
    PubMed    


    November 2019
  27. MAS S, Gasso P, Rodriguez N, Cabrera B, et al
    Personalized medicine begins with the phenotype; identifying antipsychotic response phenotypes in a first episode psychosis cohort.
    Acta Psychiatr Scand. 2019 Nov 20. doi: 10.1111/acps.13131.
    PubMed     Abstract available


  28. TAMOUZA R, Krishnamoorthy R, Giegling I, Leboyer M, et al
    The HLA 8.1 Ancestral Haplotype in schizophrenia: dual implication in neuro-synaptic pruning and autoimmunity?
    Acta Psychiatr Scand. 2019 Nov 9. doi: 10.1111/acps.13125.
    PubMed     Abstract available


    October 2019
  29. GLENTHOJ LB, Bailey B, Kristensen TD, Wenneberg C, et al
    Basic symptoms influence real-life functioning and symptoms in individuals at high risk for psychosis.
    Acta Psychiatr Scand. 2019 Oct 16. doi: 10.1111/acps.13117.
    PubMed     Abstract available


  30. AYESA-ARRIOLA R, Setien-Suero E, Marques-Feixa L, Neergaard K, et al
    The synergetic effect of childhood trauma and recent stressful events in psychosis: associated neurocognitive dysfunction.
    Acta Psychiatr Scand. 2019 Oct 16. doi: 10.1111/acps.13114.
    PubMed     Abstract available


    September 2019
  31. BROBAKKEN MF, Nygard M, Guzey IC, Morken G, et al
    Aerobic interval training in standard treatment of outpatients with schizophrenia: a randomised controlled trial.
    Acta Psychiatr Scand. 2019 Sep 29. doi: 10.1111/acps.13105.
    PubMed     Abstract available


  32. MUESER KT, DeTore NR, Kredlow MA, Bourgeois ML, et al
    Clinical and Demographic Correlates of Stigma in First Episode Psychosis: The Impact of Duration of Untreated Psychosis.
    Acta Psychiatr Scand. 2019 Sep 26. doi: 10.1111/acps.13102.
    PubMed     Abstract available


  33. GEROS H, Sizer H, Mifsud N, Reynolds S, et al
    Migrant status and identification as ultra-high risk for psychosis and transitioning to a psychotic disorder.
    Acta Psychiatr Scand. 2019 Sep 14. doi: 10.1111/acps.13099.
    PubMed     Abstract available


    August 2019
  34. LOPEZ-DIAZ A, Fernandez-Gonzalez JL, Lara I, Crespo-Facorro B, et al
    The prognostic role of catatonia, hallucinations and symptoms of schizophrenia in acute and transient psychosis.
    Acta Psychiatr Scand. 2019 Aug 22. doi: 10.1111/acps.13092.
    PubMed     Abstract available


  35. LAIDI C, Hajek T, Spaniel F, Kolenic M, et al
    Cerebellar parcellation in schizophrenia and bipolar disorder.
    Acta Psychiatr Scand. 2019 Aug 16. doi: 10.1111/acps.13087.
    PubMed     Abstract available


  36. CURKOVIC M, Borovecki A
    The Use of Placebo in Schizophrenia Relapse Prevention Studies: Scientific or Ethical Debate?
    Acta Psychiatr Scand. 2019 Aug 13. doi: 10.1111/acps.13085.
    PubMed     Abstract available


  37. SETIEN-SUERO E, Neergaard K, Ortiz-Garcia de la Foz V, Suarez-Pinilla P, et al
    Stopping cannabis use benefits outcome in psychosis: findings from 10-year follow-up study in the PAFIP-cohort.
    Acta Psychiatr Scand. 2019 Aug 5. doi: 10.1111/acps.13081.
    PubMed     Abstract available


    July 2019
  38. NILES HF, Walsh BC, Woods SW, Powers AR 3rd, et al
    Does hallucination perceptual modality impact psychosis risk?
    Acta Psychiatr Scand. 2019 Jul 29. doi: 10.1111/acps.13078.
    PubMed     Abstract available


  39. KUGATHASAN P, Stubbs B, Aagaard J, Jensen SE, et al
    Increased mortality from somatic multimorbidity in patients with schizophrenia: a Danish nationwide cohort study.
    Acta Psychiatr Scand. 2019 Jul 29. doi: 10.1111/acps.13076.
    PubMed     Abstract available


  40. PANDIT R, Cianci D, Ter Hark SE, Winter-van Rossum I, et al
    Phenotypic factors associated with amisulpride-induced weight gain in first-episode psychosis patients (from the OPTIMISE cohort).
    Acta Psychiatr Scand. 2019 Jul 19. doi: 10.1111/acps.13074.
    PubMed     Abstract available


  41. HEINS M, Achterhof R, Collip D, Viechtbauer W, et al
    Social functioning and subclinical psychosis in adolescence: A longitudinal general adolescent population study.
    Acta Psychiatr Scand. 2019 Jul 2. doi: 10.1111/acps.13069.
    PubMed     Abstract available


    June 2019
  42. GANTRIIS DL, Thorup AAE, Harder S, Greve AN, et al
    Home visits in the Danish High Risk and Resilience Study - VIA 7 Assessment of the home environment of 508 7-year-old children born to parents diagnosed with schizophrenia or bipolar disorder.
    Acta Psychiatr Scand. 2019 Jun 2. doi: 10.1111/acps.13057.
    PubMed     Abstract available


    April 2019
  43. DAMA M, Shah J, Norman R, Iyer S, et al
    Short duration of untreated psychosis enhances negative symptom remission in extended early intervention service for psychosis.
    Acta Psychiatr Scand. 2019 Apr 9. doi: 10.1111/acps.13033.
    PubMed     Abstract available


    March 2019
  44. PIRAS F, Piras F, Banaj N, Ciullo V, et al
    Cerebellar GABAergic correlates of cognition-mediated verbal fluency in physiology and schizophrenia.
    Acta Psychiatr Scand. 2019 Mar 18. doi: 10.1111/acps.13027.
    PubMed     Abstract available


  45. GOHAR SM, Dieset I, Steen NE, Morch RH, et al
    Association between Leptin Levels and Severity of Suicidal Behaviour in Schizophrenia Spectrum Disorders.
    Acta Psychiatr Scand. 2019 Mar 8. doi: 10.1111/acps.13019.
    PubMed     Abstract available


  46. SHER L, Kahn RS
    Family interventions and prevention of suicide in first-episode schizophrenia.
    Acta Psychiatr Scand. 2019 Mar 6. doi: 10.1111/acps.13018.
    PubMed     Abstract available


    February 2019
  47. DANEAULT JG, Maraj A, Lepage M, Malla A, et al
    Medication adherence in first episode psychosis: The role of pre-onset sub-threshold symptoms.
    Acta Psychiatr Scand. 2019 Feb 3. doi: 10.1111/acps.13011.
    PubMed     Abstract available


  48. STAHL SM, Greenberg GD
    Placebo response rate is ruining drug development in psychiatry: why is this happening and what can we do about it?
    Acta Psychiatr Scand. 2019;139:105-107.
    PubMed    


    January 2019
  49. RODEVAND L, Steen NE, Elvsashagen T, Quintana DS, et al
    Cardiovascular risk remain high in schizophrenia with modest improvements in bipolar disorder during past decade.
    Acta Psychiatr Scand. 2019 Jan 29. doi: 10.1111/acps.13008.
    PubMed     Abstract available


  50. SVENSSON CK, Larsen JR, Vedtofte L, Jakobsen MSL, et al
    One-year follow-up on liraglutide treatment for prediabetes and overweight/obesity in clozapine- or olanzapine-treated patients.
    Acta Psychiatr Scand. 2019;139:26-36.
    PubMed     Abstract available


  51. DIESET I, Morch RH, Hope S, Hoseth EZ, et al
    An association between YKL-40 and type 2 diabetes in psychotic disorders.
    Acta Psychiatr Scand. 2019;139:37-45.
    PubMed     Abstract available


    December 2018
  52. ONWORDI E, Howes O
    Trends in mortality in schizophrenia and their implications.
    Acta Psychiatr Scand. 2018;138:489-491.
    PubMed    


    November 2018
  53. CHO J, Hayes RD, Jewell A, Kadra G, et al
    Clozapine and all-cause mortality in treatment-resistant schizophrenia: a historical cohort study.
    Acta Psychiatr Scand. 2018 Nov 26. doi: 10.1111/acps.12989.
    PubMed     Abstract available


    October 2018
  54. OKHUIJSEN-PFEIFER C, Huijsman EAH, Hasan A, Sommer IEC, et al
    Clozapine as a first- or second-line treatment in schizophrenia: a systematic review and meta-analysis.
    Acta Psychiatr Scand. 2018;138:281-288.
    PubMed     Abstract available


    September 2018
  55. DE NIJS J, Schnack HG, Koevoets MGJC, Kubota M, et al
    Reward-related brain structures are smaller in patients with schizophrenia and comorbid metabolic syndrome.
    Acta Psychiatr Scand. 2018 Sep 27. doi: 10.1111/acps.12955.
    PubMed     Abstract available


  56. DE PIERREFEU A, Lofstedt T, Laidi C, Hadj-Selem F, et al
    Identifying a neuroanatomical signature of schizophrenia, reproducible across sites and stages, using machine learning with structured sparsity.
    Acta Psychiatr Scand. 2018 Sep 21. doi: 10.1111/acps.12964.
    PubMed     Abstract available


  57. ISLAM MA, Habtewold TD, van Es FD, Quee PJ, et al
    Long-term cognitive trajectories and heterogeneity in patients with schizophrenia and their unaffected siblings.
    Acta Psychiatr Scand. 2018 Sep 21. doi: 10.1111/acps.12961.
    PubMed     Abstract available


  58. BERRY N, Emsley R, Lobban F, Bucci S, et al
    Social media and its relationship with mood, self-esteem and paranoia in psychosis.
    Acta Psychiatr Scand. 2018 Sep 10. doi: 10.1111/acps.12953.
    PubMed     Abstract available


  59. KUBO K, Fleischhacker WW, Suzuki T, Yasui-Furukori N, et al
    Placebo effects in adult and adolescent patients with schizophrenia: combined analysis of nine RCTs.
    Acta Psychiatr Scand. 2018 Sep 9. doi: 10.1111/acps.12960.
    PubMed     Abstract available


    August 2018
  60. OSTERGAARD SD, Foldager L, Mors O, Bech P, et al
    The validity and sensitivity of PANSS-6 in treatment-resistant schizophrenia.
    Acta Psychiatr Scand. 2018 Aug 30. doi: 10.1111/acps.12952.
    PubMed     Abstract available


  61. ORHAN F, Schwieler L, Fatouros-Bergman H, Malmqvist A, et al
    Increased number of monocytes and plasma levels of MCP-1 and YKL-40 in first-episode psychosis.
    Acta Psychiatr Scand. 2018 Aug 21. doi: 10.1111/acps.12944.
    PubMed     Abstract available


  62. AMORETTI S, Cabrera B, Torrent C, Mezquida G, et al
    Cognitive reserve as an outcome predictor: first-episode affective versus non-affective psychosis.
    Acta Psychiatr Scand. 2018 Aug 14. doi: 10.1111/acps.12949.
    PubMed     Abstract available


  63. ARICAN I, Bass N, Neelam K, Wolfe K, et al
    Prevalence of attention deficit hyperactivity disorder symptoms in patients with schizophrenia.
    Acta Psychiatr Scand. 2018 Aug 13. doi: 10.1111/acps.12948.
    PubMed     Abstract available


    July 2018
  64. BUCCI P, Galderisi S, Mucci A, Rossi A, et al
    Premorbid academic and social functioning in patients with schizophrenia and its associations with negative symptoms and cognition.
    Acta Psychiatr Scand. 2018 Jul 8. doi: 10.1111/acps.12938.
    PubMed     Abstract available


  65. DONDE C, Vignaud P, Poulet E, Brunelin J, et al
    Management of depression in patients with schizophrenia spectrum disorders: a critical review of international guidelines.
    Acta Psychiatr Scand. 2018 Jul 4. doi: 10.1111/acps.12939.
    PubMed     Abstract available


  66. MACCABE JH
    It is time to start taking tobacco seriously as a risk factor for psychosis: self-medication cannot explain the association.
    Acta Psychiatr Scand. 2018;138:3-4.
    PubMed    


    June 2018
  67. TANSKANEN A, Tiihonen J, Taipale H
    Mortality in schizophrenia: 30-year nationwide follow-up study.
    Acta Psychiatr Scand. 2018 Jun 13. doi: 10.1111/acps.12913.
    PubMed     Abstract available


    April 2018
  68. RIEHLE M, Mehl S, Lincoln TM
    The specific social costs of expressive negative symptoms in schizophrenia: reduced smiling predicts interactional outcome.
    Acta Psychiatr Scand. 2018 Apr 17. doi: 10.1111/acps.12892.
    PubMed     Abstract available


  69. SUETANI S, Siskind D, Scott JG, McGrath JJ, et al
    Disentangling schizophrenia spectrum disorders.
    Acta Psychiatr Scand. 2018;137:365-366.
    PubMed    


    March 2018
  70. KRYNICKI CR, Upthegrove R, Deakin JFW, Barnes TRE, et al
    The relationship between negative symptoms and depression in schizophrenia: a systematic review.
    Acta Psychiatr Scand. 2018 Mar 13. doi: 10.1111/acps.12873.
    PubMed     Abstract available


  71. GALLING B, Vernon JA, Pagsberg AK, Wadhwa A, et al
    Efficacy and safety of antidepressant augmentation of continued antipsychotic treatment in patients with schizophrenia.
    Acta Psychiatr Scand. 2018;137:187-205.
    PubMed     Abstract available


    February 2018
  72. MUSTONEN A, Ahokas T, Nordstrom T, Murray GK, et al
    Smokin` hot: adolescent smoking and the risk of psychosis.
    Acta Psychiatr Scand. 2018 Feb 18. doi: 10.1111/acps.12863.
    PubMed     Abstract available


  73. MA CH, Chang SS, Tsai HJ, Gau SS, et al
    Comparative effect of antipsychotics on risk of self-harm among patients with schizophrenia.
    Acta Psychiatr Scand. 2018 Feb 11. doi: 10.1111/acps.12857.
    PubMed     Abstract available


    January 2018
  74. ROHDE C, Polcwiartek C, Kragholm K, Ebdrup BH, et al
    Adverse cardiac events in out-patients initiating clozapine treatment: a nationwide register-based study.
    Acta Psychiatr Scand. 2018;137:47-53.
    PubMed     Abstract available


    December 2017
  75. BELBASIS L, Kohler CA, Stefanis N, Stubbs B, et al
    Risk factors and peripheral biomarkers for schizophrenia spectrum disorders: an umbrella review of meta-analyses.
    Acta Psychiatr Scand. 2017 Dec 30. doi: 10.1111/acps.12847.
    PubMed     Abstract available


  76. LIN CH, Lin HS, Lin SC, Kuo CC, et al
    Early improvement in PANSS-30, PANSS-8, and PANSS-6 scores predicts ultimate response and remission during acute treatment of schizophrenia.
    Acta Psychiatr Scand. 2017 Dec 27. doi: 10.1111/acps.12849.
    PubMed     Abstract available


    November 2017
  77. KRAKAUER K, Nordentoft M, Glenthoj BY, Raghava JM, et al
    White matter maturation during 12 months in individuals at ultra-high-risk for psychosis.
    Acta Psychiatr Scand. 2017 Nov 16. doi: 10.1111/acps.12835.
    PubMed     Abstract available


  78. MIZUNO Y, Hofer A, Frajo-Apor B, Wartelsteiner F, et al
    Religiosity and psychological resilience in patients with schizophrenia and bipolar disorder: an international cross-sectional study.
    Acta Psychiatr Scand. 2017 Nov 15. doi: 10.1111/acps.12838.
    PubMed     Abstract available


    October 2017
  79. MCCUTCHEON R, Beck K, D'Ambrosio E, Donocik J, et al
    Antipsychotic plasma levels in the assessment of poor treatment response in schizophrenia.
    Acta Psychiatr Scand. 2017 Oct 26. doi: 10.1111/acps.12825.
    PubMed     Abstract available


    September 2017
  80. STEGMAYER K, Stettler M, Strik W, Federspiel A, et al
    Resting state perfusion in the language network is linked to formal thought disorder and poor functional outcome in schizophrenia.
    Acta Psychiatr Scand. 2017 Sep 2. doi: 10.1111/acps.12790.
    PubMed     Abstract available


    August 2017
  81. FAN X, Song X, Zhao M, Jarskog LF, et al
    The effect of adjunctive telmisartan treatment on psychopathology and cognition in patients with schizophrenia.
    Acta Psychiatr Scand. 2017 Aug 29. doi: 10.1111/acps.12799.
    PubMed     Abstract available


  82. EBDRUP BH, Ishoy PL, Fagerlund B, Broberg BV, et al
    'No cognitive-enhancing effect of GLP-1 receptor agonism in antipsychotic-treated, obese patients with schizophrenia': authors' response.
    Acta Psychiatr Scand. 2017 Aug 28. doi: 10.1111/acps.12795.
    PubMed    


  83. SPERANDEO R, Maldonato MN, Dell'Orco S
    Comment on 'No cognitive-enhancing effect of GLP-1 receptor agonism in antipsychotic-treated, obese patients with schizophrenia'.
    Acta Psychiatr Scand. 2017 Aug 4. doi: 10.1111/acps.12782.
    PubMed    


    July 2017
  84. KIM JS, Park CM, Choi JA, Park E, et al
    The association between season of birth, age at onset, and clozapine use in schizophrenia.
    Acta Psychiatr Scand. 2017 Jul 25. doi: 10.1111/acps.12776.
    PubMed     Abstract available


    June 2017
  85. CULLEN B, Smith DJ, Deary IJ, Evans JJ, et al
    The 'cognitive footprint' of psychiatric and neurological conditions: cross-sectional study in the UK Biobank cohort.
    Acta Psychiatr Scand. 2017;135:593-605.
    PubMed     Abstract available


    May 2017
  86. DEBOST JC, Debost M, Grove J, Mors O, et al
    COMT Val158Met and MTHFR C677T moderate risk of schizophrenia in response to childhood adversity.
    Acta Psychiatr Scand. 2017 May 29. doi: 10.1111/acps.12761.
    PubMed     Abstract available


  87. WEISS SRB, Blanco C, Wargo EM
    Clarifying the link between cannabis use and risk for psychosis.
    Acta Psychiatr Scand. 2017 May 29. doi: 10.1111/acps.12764.
    PubMed    


  88. WALTON E, Hibar DP, van Erp TG, Potkin SG, et al
    Positive symptoms associate with cortical thinning in the superior temporal gyrus via the ENIGMA Schizophrenia consortium.
    Acta Psychiatr Scand. 2017;135:439-447.
    PubMed     Abstract available


  89. VERDOUX H, Pambrun E, Tournier M, Bezin J, et al
    Risk of discontinuation of antipsychotic long-acting injections vs. oral antipsychotics in real-life prescribing practice: a community-based study.
    Acta Psychiatr Scand. 2017;135:429-438.
    PubMed     Abstract available


    March 2017
  90. NUNEZ C, Paipa N, Senior C, Coromina M, et al
    Global brain asymmetry is increased in schizophrenia and related to avolition.
    Acta Psychiatr Scand. 2017 Mar 23. doi: 10.1111/acps.12723.
    PubMed     Abstract available


    February 2017
  91. JAKOBSEN MI, Larsen JR, Svensson CK, Johansen SS, et al
    The significance of sampling time in therapeutic drug monitoring of clozapine.
    Acta Psychiatr Scand. 2017;135:159-169.
    PubMed     Abstract available


  92. KOHLER O, Petersen L, Mors O, Mortensen PB, et al
    Infections and exposure to anti-infective agents and the risk of severe mental disorders: a nationwide study.
    Acta Psychiatr Scand. 2017;135:97-105.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Schizophrenia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: